Core Insights - The Qingdao Free Trade Zone has strategically developed the life and health industry, with 69 projects, 5 provincial-level R&D institutions, and over 3,700 talents in the sector [1] Group 1: Industry Development - The Qingdao Free Trade Zone has established a strong foundation for the life and health industry, focusing on basic research, applied research, and industrial transformation [1] - The region has successfully introduced over 10 biopharmaceutical companies, leveraging leading enterprises to create a 288,000 square meter development platform for the life and health industry [1] Group 2: Technological Innovation - Breakthroughs in various cutting-edge technology fields have been achieved, including over 100 authorized invention patents in molecular breeding and more than 200 PCT international invention patents [1] - The global first immune anti-tumor marine polysaccharide new drug BG136 is expected to release its phase II clinical report in March [1] Group 3: Future Plans - The Qingdao Free Trade Zone aims to introduce 18 globally leading projects in exosome and cell transformation applications by 2025, doubling the number of projects within two years [1] - The focus will be on exploring application scenarios and optimizing the life and health industry ecosystem to better serve enterprise development [2]

Group 1 - The Qingdao Free Trade Zone has strategically planned the development of the life and health industry, achieving significant progress with 69 projects and the establishment of 5 provincial-level research institutions [1] - The industry has attracted over 3,700 talents and has been recognized for its potential in gene technology, with the gene technology industry cluster included in Shandong Province's future industry clusters [1] - The global first immune anti-tumor marine polysaccharide new drug BG136 is expected to release its phase II clinical report in March, showcasing the collaborative innovation efforts of various research institutions [1] Group 2 - The Qingdao Free Trade Zone has made breakthroughs in multiple cutting-edge technology fields, with over 100 invention patents authorized and more than 200 PCT international invention patents authorized [1] - Three leading enterprises, Guoxin Pharmaceutical, BGI, and Qingyuan, have established operations in the zone, which has developed a 288,000 square meter facility for the life and health industry [1] - The zone aims to introduce 18 new projects related to exosomes and cell transformation applications by 2025, indicating a doubling of project numbers within two years [1][2]